FDA Drug Application (020538) for VIVELLE-DOT by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020538
Product Number005
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage0.0375MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIVELLE-DOT
Active IngredientESTRADIOL



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.